Changing landscape: psychological care in the era of cystic fibrosis transmembrane conductance regulator modulators. Issue 6 (November 2020)

• Record Type: Journal Article
• Authors: Havermans, Trudy; Duff, Alistair J.A.
• Is Part Of: Current opinion in pulmonary medicine. Volume 26:Issue 6(2020:Nov.)
• Publication Date: 2020-11
• Subjects: adherence -- cystic fibrosis transmembrane conductance regulator modulators -- cystic fibrosis -- diagnosis -- psychology; Respiratory organs -- Diseases -- Periodicals; 616.24
• DOI: 10.1097/MCP.0000000000000727
• Languages: English
• ISSNs: 1070-5287

Abstract

Abstract : Purpose of review: The current review provides an overview of key psychological issues and challenges for the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) modulator era of care. It discusses research from diagnosis and beyond, to patient-team communication with a particular focus on medical trials, adherence and living with CFTR modulators. Recent findings: The impact of the diagnosis on parents is immense and the complexity of treatment now and in the future, are a challenge for both parents and teams. Communicating digitally is starting to become daily practice for many in CF care, with coronavirus disease 2019 accelerating this process. Participating in trials has a psychological impact, but most of all the (delayed) access and timing of accessing CFTR modulators is an important theme. Adherence remains of significance, both to 'old' and 'new' treatments. Living with CF in the era of CFTR modulators is beginning to impact on patients' quality of life, including new possibilities, opportunities and challenges. Summary: Psychological care needs to engage and keep pace with the rapid medical changes. Some care priorities remain the same, including psychological screening and assessment, as well as psychoeducation, communication training and psychotherapy. The presence of CF psychologist in the CF clinic remains as important as ever.